Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCORE
Julien Dreyfus,Fernando Juarez-Casso,Alessandra Sala,Manuel Carnero-Alcazar,Andrea Eixerés-Esteve,Yohann Bohbot,Baptiste Bazire,Michele Flagiello,Elisabeth Riant,Yannick Mbaki,Jacques Tomasi,Thomas Senage,Kenza Rahmouni El Idrissi,Augustin Coisne,Damien Eyharts,Fabien Doguet,Florence Viau,Florian Eggenspieler,Samuel Heuts,Peyman Sardari Nia,Gregor Heitzinger,Xavier Galloo,Nina Ajmone Marsan,Giovanni Benfari,Luigi Badano,Denisa Muraru,Francesco Maisano,Yan Topilsky,Hector Michelena,Maurice Enriquez-Sarano,Jeroen Bax,Philipp Bartko,Christine Selton-Suty,Gilbert Habib,Yoan Lavie-Badie,Thomas Modine,Vincent Chan,Thierry Le Tourneau,Erwan Donal,Pascal Lim,Costin Radu,Jordan Bernick,George A Wells,Christophe Tribouilloy,Bernard Iung,Jean-François Obadia,Michele De Bonis,Juan Crestanello,David Messika-Zeitoun,TRIGISTRY investigators,Hannes Alessandrini,Rodrigo Estevez Loureiro,Mara Gavazzoni,Rebecca Hahn,Jörg Hausleiter,Dominique Himbert,Christos Iliadis,Karl-Patrick Kresoja,Azeem Latib,Alexander Lauten,Edith Lubos,Philipp Lurz,Mohammed Nejjari,Georg Nickenig,Martin Nicol,Luis Nombela-Franco,Hazem Omran,Giovanni Pedrazzini,Roman Pfister,Kerstin Piayda,Fabien Praz,Josep Rodés-Cabau,Volker Rudolph,Tobias Ruf,Giulio Russo,Joachim Schofer,Horst Sievert,Lukas Stolz,Gilbert H L Tang,Maurizio Taramasso,Ralph Stephan von Bardeleben,Marina Urena Alcazar,John Webb,Marcel Weber,Stephan Windecker,Jose Luis Zamorano
DOI: https://doi.org/10.1093/eurheartj/ehae578
2024-08-30
Abstract:Background and aims: Severe tricuspid regurgitation (TR) is associated with increased mortality rates, but benefit of its correction and ideal timing are not clearly determined. This study aimed to identify patient subsets who might benefit from surgery. Methods: In TRIGISTRY, an international cohort study of consecutive patients with severe isolated functional TR (33 centers, 10 countries), survival rates up to 10 years were compared between patients who underwent isolated tricuspid valve (TV) surgery (repair or replacement) and those conservatively managed, overall and according to TRI-SCORE category (low: ≤3, intermediate: 4-5, high: ≥6). Results: 1,217 were managed conservatively, and 551 underwent isolated TV surgery (200 repairs, 351 replacements). TRI-SCORE distribution was 33% low, 32% intermediate, and 35% high. At 10 years, survival rates were similar between surgical and conservative management (41% vs. 36%; hazard ratio [HR] 0.97; 95% confidence interval [CI] 0.88-1.08, P=0.57). Surgery improved survival compared to conservative management in the low TRI-SCORE category (72% vs. 44%; HR 0.27; 95% CI 0.20-0.37, P<0.0001), but not in the intermediate (36% vs. 37%, HR 1.17; 95%CI 0.98-1.40, P=0.09) or high categories (20% vs. 24%; HR 1.06; 95% CI 0.91-1.25, P=0.45). Both repair and replacement improved survival in the low TRI-SCORE category (84% and 61% vs. 44%; HR 0.11; 95% CI 0.06-0.19, P<0.0001, and HR 0.65; 95% CI 0.47-0.90, P=0.009). Repair showed benefit in the intermediate category (59% vs. 37%; HR 0.49; 95% CI 0.35-0.68, P<0.0001) while replacement was possibly harmful (25% vs. 37%; HR 1.43; 95% CI 1.18-1.72, P=0.0002). Conclusions: Higher survival rates were observed with repair than replacement and benefit of intervention declined as TRI-SCORE increased with no benefit of any type of surgery in the high TRI-SCORE category. These results emphasize the importance of timely intervention and patient selection to achieve the best outcomes and the need for randomized controlled trials. Trial registration: TRIGISTRY: ClinicalTrials.gov, NCT05825898.